Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Female Infertility Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Female Infertility Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Parenteral 1.4.3 Oral 1.4.4 Others 1.5 Market by Application 1.5.1 Global Female Infertility Drugs Market Share by Application: 2020 VS 2026 1.5.2 Ovarian Hyperstimulation Syndrome 1.5.3 Multiple-gestation Pregnancies 1.5.4 Multiple-birth Infants 1.5.5 Premature Labor 1.5.6 Low Birth Weight 1.5.7 Risk of Cesarean Delivery 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Female Infertility Drugs Market Perspective (2015-2026) 2.2 Female Infertility Drugs Growth Trends by Regions 2.2.1 Female Infertility Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Female Infertility Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Female Infertility Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Female Infertility Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Female Infertility Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Female Infertility Drugs Players by Market Size 3.1.1 Global Top Female Infertility Drugs Players by Revenue (2015-2020) 3.1.2 Global Female Infertility Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Female Infertility Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Female Infertility Drugs Market Concentration Ratio 3.2.1 Global Female Infertility Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Female Infertility Drugs Revenue in 2019 3.3 Female Infertility Drugs Key Players Head office and Area Served 3.4 Key Players Female Infertility Drugs Product Solution and Service 3.5 Date of Enter into Female Infertility Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Female Infertility Drugs Historic Market Size by Type (2015-2020) 4.2 Global Female Infertility Drugs Forecasted Market Size by Type (2021-2026) 5 Female Infertility Drugs Breakdown Data by Application (2015-2026) 5.1 Global Female Infertility Drugs Market Size by Application (2015-2020) 5.2 Global Female Infertility Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Female Infertility Drugs Market Size (2015-2020) 6.2 Female Infertility Drugs Key Players in North America (2019-2020) 6.3 North America Female Infertility Drugs Market Size by Type (2015-2020) 6.4 North America Female Infertility Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Female Infertility Drugs Market Size (2015-2020) 7.2 Female Infertility Drugs Key Players in Europe (2019-2020) 7.3 Europe Female Infertility Drugs Market Size by Type (2015-2020) 7.4 Europe Female Infertility Drugs Market Size by Application (2015-2020) 8 China 8.1 China Female Infertility Drugs Market Size (2015-2020) 8.2 Female Infertility Drugs Key Players in China (2019-2020) 8.3 China Female Infertility Drugs Market Size by Type (2015-2020) 8.4 China Female Infertility Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Female Infertility Drugs Market Size (2015-2020) 9.2 Female Infertility Drugs Key Players in Japan (2019-2020) 9.3 Japan Female Infertility Drugs Market Size by Type (2015-2020) 9.4 Japan Female Infertility Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Female Infertility Drugs Market Size (2015-2020) 10.2 Female Infertility Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Female Infertility Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Female Infertility Drugs Market Size by Application (2015-2020) 11 India 11.1 India Female Infertility Drugs Market Size (2015-2020) 11.2 Female Infertility Drugs Key Players in India (2019-2020) 11.3 India Female Infertility Drugs Market Size by Type (2015-2020) 11.4 India Female Infertility Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Female Infertility Drugs Market Size (2015-2020) 12.2 Female Infertility Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Female Infertility Drugs Market Size by Type (2015-2020) 12.4 Central & South America Female Infertility Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Allergan Plc 13.1.1 Allergan Plc Company Details 13.1.2 Allergan Plc Business Overview and Its Total Revenue 13.1.3 Allergan Plc Female Infertility Drugs Introduction 13.1.4 Allergan Plc Revenue in Female Infertility Drugs Business (2015-2020)) 13.1.5 Allergan Plc Recent Development 13.2 Ferring BV 13.2.1 Ferring BV Company Details 13.2.2 Ferring BV Business Overview and Its Total Revenue 13.2.3 Ferring BV Female Infertility Drugs Introduction 13.2.4 Ferring BV Revenue in Female Infertility Drugs Business (2015-2020) 13.2.5 Ferring BV Recent Development 13.3 Merck KGaA 13.3.1 Merck KGaA Company Details 13.3.2 Merck KGaA Business Overview and Its Total Revenue 13.3.3 Merck KGaA Female Infertility Drugs Introduction 13.3.4 Merck KGaA Revenue in Female Infertility Drugs Business (2015-2020) 13.3.5 Merck KGaA Recent Development 13.4 Novartis AG 13.4.1 Novartis AG Company Details 13.4.2 Novartis AG Business Overview and Its Total Revenue 13.4.3 Novartis AG Female Infertility Drugs Introduction 13.4.4 Novartis AG Revenue in Female Infertility Drugs Business (2015-2020) 13.4.5 Novartis AG Recent Development 13.5 Sanofi 13.5.1 Sanofi Company Details 13.5.2 Sanofi Business Overview and Its Total Revenue 13.5.3 Sanofi Female Infertility Drugs Introduction 13.5.4 Sanofi Revenue in Female Infertility Drugs Business (2015-2020) 13.5.5 Sanofi Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Female Infertility Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Female Infertility Drugs Revenue Table 3. Ranking of Global Top Female Infertility Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Female Infertility Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Parenteral Table 6. Key Players of Oral Table 7. Key Players of Others Table 8. Global Female Infertility Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Female Infertility Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Female Infertility Drugs Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Female Infertility Drugs Market Share by Regions (2015-2020) Table 12. Global Female Infertility Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Female Infertility Drugs Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Female Infertility Drugs Market Growth Strategy Table 18. Main Points Interviewed from Key Female Infertility Drugs Players Table 19. Global Female Infertility Drugs Revenue by Players (2015-2020) (Million US$) Table 20. Global Female Infertility Drugs Market Share by Players (2015-2020) Table 21. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Drugs as of 2019) Table 22. Global Female Infertility Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Female Infertility Drugs Product Solution and Service Table 25. Date of Enter into Female Infertility Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 28. Global Female Infertility Drugs Market Size Share by Type (2015-2020) Table 29. Global Female Infertility Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Female Infertility Drugs Market Size Share by Application (2015-2020) Table 31. Global Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 32. Global Female Infertility Drugs Market Size Share by Application (2021-2026) Table 33. North America Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 34. North America Key Players Female Infertility Drugs Market Share (2019-2020) Table 35. North America Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 36. North America Female Infertility Drugs Market Share by Type (2015-2020) Table 37. North America Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 38. North America Female Infertility Drugs Market Share by Application (2015-2020) Table 39. Europe Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Female Infertility Drugs Market Share (2019-2020) Table 41. Europe Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 42. Europe Female Infertility Drugs Market Share by Type (2015-2020) Table 43. Europe Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 44. Europe Female Infertility Drugs Market Share by Application (2015-2020) Table 45. China Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 46. China Key Players Female Infertility Drugs Market Share (2019-2020) Table 47. China Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 48. China Female Infertility Drugs Market Share by Type (2015-2020) Table 49. China Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 50. China Female Infertility Drugs Market Share by Application (2015-2020) Table 51. Japan Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Female Infertility Drugs Market Share (2019-2020) Table 53. Japan Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 54. Japan Female Infertility Drugs Market Share by Type (2015-2020) Table 55. Japan Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 56. Japan Female Infertility Drugs Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Female Infertility Drugs Market Share (2019-2020) Table 59. Southeast Asia Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Female Infertility Drugs Market Share by Type (2015-2020) Table 61. Southeast Asia Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Female Infertility Drugs Market Share by Application (2015-2020) Table 63. India Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 64. India Key Players Female Infertility Drugs Market Share (2019-2020) Table 65. India Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 66. India Female Infertility Drugs Market Share by Type (2015-2020) Table 67. India Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 68. India Female Infertility Drugs Market Share by Application (2015-2020) Table 69. Central & South America Key Players Female Infertility Drugs Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Female Infertility Drugs Market Share (2019-2020) Table 71. Central & South America Female Infertility Drugs Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Female Infertility Drugs Market Share by Type (2015-2020) Table 73. Central & South America Female Infertility Drugs Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Female Infertility Drugs Market Share by Application (2015-2020) Table 75. Allergan Plc Company Details Table 76. Allergan Plc Business Overview Table 77. Allergan Plc Product Table 78. Allergan Plc Revenue in Female Infertility Drugs Business (2015-2020) (Million US$) Table 79. Allergan Plc Recent Development Table 80. Ferring BV Company Details Table 81. Ferring BV Business Overview Table 82. Ferring BV Product Table 83. Ferring BV Revenue in Female Infertility Drugs Business (2015-2020) (Million US$) Table 84. Ferring BV Recent Development Table 85. Merck KGaA Company Details Table 86. Merck KGaA Business Overview Table 87. Merck KGaA Product Table 88. Merck KGaA Revenue in Female Infertility Drugs Business (2015-2020) (Million US$) Table 89. Merck KGaA Recent Development Table 90. Novartis AG Company Details Table 91. Novartis AG Business Overview Table 92. Novartis AG Product Table 93. Novartis AG Revenue in Female Infertility Drugs Business (2015-2020) (Million US$) Table 94. Novartis AG Recent Development Table 95. Sanofi Company Details Table 96. Sanofi Business Overview Table 97. Sanofi Product Table 98. Sanofi Revenue in Female Infertility Drugs Business (2015-2020) (Million US$) Table 99. Sanofi Recent Development Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Global Female Infertility Drugs Market Share by Type: 2020 VS 2026 Figure 2. Parenteral Features Figure 3. Oral Features Figure 4. Others Features Figure 5. Global Female Infertility Drugs Market Share by Application: 2020 VS 2026 Figure 6. Ovarian Hyperstimulation Syndrome Case Studies Figure 7. Multiple-gestation Pregnancies Case Studies Figure 8. Multiple-birth Infants Case Studies Figure 9. Premature Labor Case Studies Figure 10. Low Birth Weight Case Studies Figure 11. Risk of Cesarean Delivery Case Studies Figure 12. Female Infertility Drugs Report Years Considered Figure 13. Global Female Infertility Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Female Infertility Drugs Market Share by Regions: 2020 VS 2026 Figure 15. Global Female Infertility Drugs Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Female Infertility Drugs Market Share by Players in 2019 Figure 18. Global Top Female Infertility Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Drugs as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Female Infertility Drugs Revenue in 2019 Figure 20. North America Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. China Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Japan Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Southeast Asia Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. India Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Central & South America Female Infertility Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Allergan Plc Revenue Growth Rate in Female Infertility Drugs Business (2015-2020) Figure 29. Ferring BV Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Ferring BV Revenue Growth Rate in Female Infertility Drugs Business (2015-2020) Figure 31. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck KGaA Revenue Growth Rate in Female Infertility Drugs Business (2015-2020) Figure 33. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Novartis AG Revenue Growth Rate in Female Infertility Drugs Business (2015-2020) Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Sanofi Revenue Growth Rate in Female Infertility Drugs Business (2015-2020) Figure 37. Bottom-up and Top-down Approaches for This Report Figure 38. Data Triangulation Figure 39. Key Executives Interviewed

Allergan Plc Ferring BV Merck KGaA Novartis AG Sanofi